Publications
- Komentář ke druhé interní analýze evropské observační studie účinnosti fremanezumabu – PEARL2023 | First Faculty of Medicine
- Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study2023 | First Faculty of Medicine
- Acute Medication Use in Patients With Migraine Treated With Monoclonal Antibodies Acting on the CGRP Pathway: Results From a Multicenter Study and Proposal of a New Index2022 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study2022 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Aktuální postupy v léčbě migrény2022 | First Faculty of Medicine
- CGRP antibodies in the prophylactic treatment of migraine2022 | First Faculty of Medicine
- Opinion of the Section for headache diagnosis and treatment of the Czech Neurological Society CLS JEP on the staff and technical equipment of the headache diagnostic and treatment centers and on the organization way of their sites focusing on the biological treatment of migraine2022 | First Faculty of Medicine
- Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men2021 | First Faculty of Medicine, Central Library of Charles University
- Galkanezumab - nová biologická léčba migrény2021 | First Faculty of Medicine
- Epilepsy in adults - a practical view2021 | First Faculty of Medicine
Loading network view...
